Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trial
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trial
Nino Emanuel Landler, Joshua Nealon, Brian Lee Claggett, Matthew M. Loiacono et al.
Citations
7 citations
Journal
Journal of Infection
Topics
Influenza Virus Research Studies
Field-Weighted Citation Impact (FWCI)
2.32
article
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trial
Nino Emanuel Landler, Joshua Nealon, Brian Lee Claggett, Matthew M. Loiacono, Anne Marie Reimer Jensen, Kristoffer Grundtvig Skaarup, Lars Køber, Gunnar Gislason, Jacob Christensen, Jens‐Ulrik Stæhr Jensen, Sandrine Samson, Scott David Solomon, Carsten Schade Larsen, Daniel Modin, Kira Hyldekær Janstrup, Rebecca C. Harris, Martin Landray, Niklas Dyrby Johansen, Tor Biering‐Sørensen, Pradeesh Sivapalan
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of InfectionVol. 89(5)
Institutions
Brigham and Women's Hospital (US), Harvard University (US), Aarhus University Hospital (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK), Sanofi (France) (FR), University of Oxford (GB), Sanofi (United States) (US), Swift Engineering (United States) (US)